1. Nottage MK, Kopciuk KA, Tzontcheva A, Andrulis IL, Bull SB, Blackstein ME. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on diseasespecific survival of women with node-negative breast cancer. a prospective cohort study. Breast Cancer Res. 2006; 8: 44. [
DOI:10.1186/bcr1531] [
PMID] [
PMCID]
2. Center of management of noncontiguous diseases. IRAN Ministry of Health and Medical Education. Iran. Cancer Registry Report. 2015; 21: 1-10.
3. Azizi F, Hatami H, Janghorban M. Epidemiology and control of common diseases. Tehran: Publication of Eshtiagh. 2000; 7-10.
4. Jason P, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc .1999; 94: 496-509. [
DOI:10.1080/01621459.1999.10474144]
5. Klein JP, Bajorunaite R. Inference for competing risks, In: Advances in survival analysis, Handbook of statistics. Amsterdam: Elsevier. 2004; 291-311. [
DOI:10.1016/S0169-7161(03)23016-9]
6. Tai BC, Wee J, Machin D. Analysis and design of randomised clinical trials involving competing risks endpoints. Trials. 2011; 12: 127. [
DOI:10.1186/1745-6215-12-127] [
PMID] [
PMCID]
7. Zhang M, Zhang XU, Scheike T. Modeling cumulative incidence function for competing risks data. Expert Rev Clin Pharmacol. 2008; 1: 391-400. [
DOI:10.1586/17512433.1.3.391] [
PMID] [
PMCID]
8. Jafarabadi M, Mohammadi M, Hajizade E, Fatemi R. An evulation of 5-year survival of metastatic colon and rectal cancer patients using cumulative incidence models. Koomesh. 2013. 2: 207-214.
9. Nazemi pur M, Mahmoodi M, Zeraati H, Rahimi Furushani A. Analyze the survival of patients with gastric cancer after surgery, based on a flexible model for competing risks. School of Public Health and Institute of Health Research. 2012; 27-38.
10. McArdle CS, McMillan DC, Greenlaw N, Morrison DS. Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival. BMC Cancer. 2010; 10: 398 [
DOI:10.1186/1471-2407-10-398] [
PMID] [
PMCID]
11. Grambauer N, Schumacher M, Beyersmann J. Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified. Stat Med. 2010; 29: 875-84. [
DOI:10.1002/sim.3786] [
PMID]
12. Mell LK, Jeong JH, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ. Predictors of competing mortality in early breast cancer. Cancer. 2010; 116: 5365-73. [
DOI:10.1002/cncr.25370] [
PMID]
13. Lim HJ, Zhang X, Dyck R, Osgood N. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes. BMC Med Res Methodol. 2010; 10: 97. [
DOI:10.1186/1471-2288-10-97] [
PMID] [
PMCID]
14. Torner A.Proportional hazards and additive regression analysis of survival for severe breast cancer.Stockholm: Mathematical Statistic Stockholm University; 2004.
15. Baldi I, Ciccone G, Ponti A, Rosso S, Zanetti R, Gregori D. An application of the cox-aalen model for breast cancer survival. Austrian J statistics. 2006; 35: 77-88. [
DOI:10.17713/ajs.v35i1.350]
16. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival analysis. Br J Cancer. 2004; 91: 1229-35. [
DOI:10.1038/sj.bjc.6602102] [
PMID] [
PMCID]
17. Robson ME, Chappuis PO, Satagopan J, et al. A combined analysis of outcome following breast cancer. differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res. 2004; 6: 8-17. [
DOI:10.1186/bcr658] [
PMID] [
PMCID]
18. Olsen J, Christensen K, Murray J, Ekbom A. An introduction to epidemiology for health professionals. New York: Springer, 2010; 5: 14-16.
19. Putter H, Andersen P, Geskus R. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012; 41: 861-70. [
DOI:10.1093/ije/dyr213] [
PMID] [
PMCID]
20. Klein JP. Modelling competing risks in cancer studies. Stat Med. 2006; 25: 1015-34. [
DOI:10.1002/sim.2246] [
PMID]
21. Latouche A, Boisson V, Chevret S, Porcher R. Misspecified regression model for the subdistribution hazard of a competing risk. Stat Med. 2007; 26: 965-74. [
DOI:10.1002/sim.2600] [
PMID]
22. Wolbers M, Koller M, Witteman J. Concordance for prognostic models with competing risks. University of Copenhagen, Department of Biostatistics; 2013. [
DOI:10.1093/biostatistics/kxt059] [
PMID] [
PMCID]